Biotech Stocks Facing FDA Decision In January 2025
As we enter the new year, all eyes are on the biotech companies awaiting key FDA decisions in January. In 2024, the FDA approved 50 ...
Minnesota Daily2 天
Halsey’s ‘The Great Impersonator’ is a vulnerable journey through genres
The 30-year-old artist, who uses she/they pronouns, said in an interview with PAPER magazine they had been diagnosed with a rare T-cell lymphoproliferative disorder on their birthday ... The diagnosis ...
Medscape3 天
Atypical Lymphoid Proliferations
It is possible that AtLP represent multiclonal B cells, T cells or NK-cell lymphoproliferative processes ... During this process, the transformed lymphocytes (atypical lymphocytes) must, in ...
Pharmaceutical Technology3 天
Calquence by AstraZeneca for Follicular Lymphoma: Likelihood of Approval
Calquence is under clinical development by AstraZeneca and currently in Phase III for Follicular Lymphoma. According to GlobalData, Phase III drugs for Follicular Lymphoma have a 55% phase transition ...
Pharmaceutical Technology3 天
Calquence by AstraZeneca for Anti-MAG Peripheral Neuropathy: Likelihood of Approval
Calquence is under clinical development by AstraZeneca and currently in Phase II for Anti-MAG Peripheral Neuropathy.
pharmaphorum6 天
With landmark approval, spotlight on cryogenic logistics intensifies
The specialised process underscores the demand for charging centers in strategic markets worldwide to enable efficient and timely cryogenic shipments. The approval of Ebvallo reflects the ...
Medscape6 天
Gene Therapy for Inherited, Inflammatory and Infectious Diseases of the Lung
It was proposed that transfer of a normal copy of a single defective gene would compensate for the damaged originals and revert the disease process. Cystic fibrosis (CF), α1-antitrypsin ...